Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Critical Care Medicine|June 1, 1995
Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trialS M Willatts, S Radford, M LeitermannAnaesthesia|June 1, 1983
Training in intensive care. A questionnaire to traineesK Hillman, C J Hinds, S M WillattsAnaesthesia|December 1, 1995
Health and activity after intensive careJ Munn, S M Willatts, M A TooleyAnesthesia and Analgesia|December 1, 1991
Plasma inorganic fluoride concentrations during and after prolonged (greater than 24 h) isoflurane sedation: effect on renal functionE M Spencer, S M Willatts, C Prys-RobertsJournal of the Royal Society of Medicine|February 1, 1994
APACHE II scoring system on a general intensive care unit: audit of daily APACHE II scores and 6-month survival of 691 patients admitted to a general intensive care unit between May 1990 and December 1991N N Campbell, M A Tooley, S M WillattsAnaesthesia|September 1, 1994
Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapyS M Willatts, D C Speller, R J WinterBritish Journal of Anaesthesia|November 1, 1994
Continuous monitoring of depth of sedation by EEG spectral analysis in patients requiring mechanical ventilationE M Spencer, J L Green, S M WillattsBMJ (Clinical Research Ed.)|May 13, 1989
Isoflurane compared with midazolam for sedation in the intensive care unitK L Kong, S M Willatts, C Prys-RobertsBritish Journal of Anaesthesia|February 1, 1990
Isoflurane sedation for patients undergoing mechanical ventilation: metabolism to inorganic fluoride and renal effectsK L Kong, J E Tyler, S M Willatts, et al.Anaesthesia|January 1, 1984
Etomidate by infusion for neuroanaesthesia. Kinetic and dynamic interactions with nitrous oxideJ W Sear, F J Walters, D G Wilkins, et al.Pageof 3